Search Results 1831-1840 of 23532 for Lesion

1. Gastroenterology and Hepatology - Clinical trials

   A Study to Evaluate the Use of Confocal Laser Endomicroscopy as an IMaging Biomarker (CLIMB Study) for the Diagnosis of Pancreatic Cystic Lesions. Scottsdale ...

2. CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome - Mayo Clinic

   The participant has > 20 clinically suspicious lesions on the face at time of randomization. The participant has used topical or systemic treatment that ...

3. Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer - Mayo Clinic

   NOTE: Tumor lesions in previously irradiated area are considered measurable if previous evidence of progression has been found in these lesions * Eastern ...

4. A Study of Zorevunersen (STK-001) in Patients with Dravet Syndrome - Mayo Clinic

   No past history of causal magnetic resonance imaging (MRI) lesion (past MRI or studyassociated MRI not required to confirm absence of lesion). No other ...

5. Cancer Resource Center - Medical Professionals - Mayo Clinic

   New drug helps Mayo Clinic surgeons detect smaller lesions with greater accuracy during lung cancer surgery. Mayo Clinic in Arizona pioneers the use of ...

6. 177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer - Mayo Clinic

   ... lesions(s) by bone scan (PCWG3 criteria (Scher et al 2016)) 9. Participants must have ≥ 1 metastatic lesion that is present on screening/baseline CT, MRI ...

7. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

   Patients must have at least 1 measurable lesion according to mRECIST Version 1.1 (non-nodal lesions must be ≥ 1.0 cm in the long axis or ≥ double the ...

8. STI-3031 Through Sofusa DoseConnect for Treatment of Intransit Melanoma - Mayo Clinic

   A visible superficial ITM, non-nodal lesion with longest diameter ≥ 0.2 cm ... Prior radiation of ITM that are being evaluated as measurable lesions.

9. Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer - Mayo Clinic

   No radiographic evidence of cavitating pulmonary lesion(s); No tumor invading ... lesions that can be accurately measured in at least one dimension ...

10. S1211, Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma - Mayo Clinic

    No zidovudine or stavudine as part of ART. Patients must have baseline skeletal survey to document lytic lesions, osteopenia, or compression fracture ...